Virtus LifeSci Biotech Products ETF (BBP)

Assets	$22.03M
Expense Ratio	0.79%
PE Ratio	n/a
Shares Out	400,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	+0.43%

Volume	2,684
Open	55.30
Previous Close	53.82
Day's Range	54.86 - 55.68
52-Week Low	48.65
52-Week High	69.12
Beta	0.57
Holdings	64
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

23.29% of assets

Name	Symbol	Weight
Halozyme Therapeutics, Inc.	HALO	2.64%
Kiniksa Pharmaceuticals International, plc	KNSA	2.47%
BeiGene, Ltd.	ONC	2.43%
BioCryst Pharmaceuticals, Inc.	BCRX	2.43%
BridgeBio Pharma, Inc.	BBIO	2.35%
Ascendis Pharma A/S	ASND	2.27%
SpringWorks Therapeutics, Inc.	SWTX	2.22%
Sage Therapeutics, Inc.	SAGE	2.20%
Axsome Therapeutics, Inc.	AXSM	2.15%
Travere Therapeutics, Inc.	TVTX	2.13%